GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » ROE % Adjusted to Book Value

U-Neuron Biomedical (ROCO:6973) ROE % Adjusted to Book Value : -3.16% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical ROE % Adjusted to Book Value?

U-Neuron Biomedical's ROE % for the quarter that ended in Dec. 2023 was -11.37%. U-Neuron Biomedical's PB Ratio for the quarter that ended in Dec. 2023 was 3.60. U-Neuron Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -3.16%.


U-Neuron Biomedical ROE % Adjusted to Book Value Historical Data

The historical data trend for U-Neuron Biomedical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical ROE % Adjusted to Book Value Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - -7.20

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value - - - - -3.16

Competitive Comparison of U-Neuron Biomedical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, U-Neuron Biomedical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's ROE % Adjusted to Book Value falls into.



U-Neuron Biomedical ROE % Adjusted to Book Value Calculation

U-Neuron Biomedical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-25.91% / 3.60
=-7.20%

U-Neuron Biomedical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-11.37% / 3.60
=-3.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines